全文获取类型
收费全文 | 6104篇 |
免费 | 400篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 106篇 |
儿科学 | 299篇 |
妇产科学 | 116篇 |
基础医学 | 637篇 |
口腔科学 | 92篇 |
临床医学 | 504篇 |
内科学 | 1341篇 |
皮肤病学 | 115篇 |
神经病学 | 378篇 |
特种医学 | 133篇 |
外科学 | 1123篇 |
综合类 | 110篇 |
一般理论 | 3篇 |
预防医学 | 386篇 |
眼科学 | 266篇 |
药学 | 514篇 |
中国医学 | 19篇 |
肿瘤学 | 376篇 |
出版年
2023年 | 54篇 |
2022年 | 110篇 |
2021年 | 233篇 |
2020年 | 137篇 |
2019年 | 182篇 |
2018年 | 226篇 |
2017年 | 150篇 |
2016年 | 176篇 |
2015年 | 186篇 |
2014年 | 275篇 |
2013年 | 290篇 |
2012年 | 408篇 |
2011年 | 411篇 |
2010年 | 263篇 |
2009年 | 221篇 |
2008年 | 364篇 |
2007年 | 401篇 |
2006年 | 419篇 |
2005年 | 326篇 |
2004年 | 324篇 |
2003年 | 285篇 |
2002年 | 223篇 |
2001年 | 101篇 |
2000年 | 68篇 |
1999年 | 56篇 |
1998年 | 51篇 |
1997年 | 28篇 |
1996年 | 42篇 |
1995年 | 23篇 |
1994年 | 24篇 |
1993年 | 26篇 |
1992年 | 31篇 |
1991年 | 33篇 |
1990年 | 25篇 |
1989年 | 30篇 |
1988年 | 37篇 |
1987年 | 37篇 |
1986年 | 27篇 |
1985年 | 18篇 |
1984年 | 22篇 |
1983年 | 13篇 |
1982年 | 12篇 |
1981年 | 10篇 |
1980年 | 16篇 |
1977年 | 9篇 |
1975年 | 14篇 |
1973年 | 12篇 |
1972年 | 10篇 |
1971年 | 9篇 |
1970年 | 17篇 |
排序方式: 共有6518条查询结果,搜索用时 15 毫秒
101.
BB10010/MIP-1 alpha reduces the number of proliferating cells in the small intestine, strongly suggesting a radioprotective potential in this organ. This study was designed to optimize BB10010 administration for maximal radioprotection. In single administration protocols 1 or 4 mg/kg of BB10010 was injected into mice 2, 4 or 10 hr before death. In double administration protocols an initial dose of either 0.4 or 200 g/kg, and a second dose (2.5 hr apart) of 200 g/kg 4 hr before death were administered. The number of vincristine-arrested metaphases were counted on individually microdissected crypts from the midpoint of the small intestine. When compared to the smaller doses of BB 10010 used in our previous studies, the higher doses used in these experiments did not result in any further reduction in the number of proliferating cells under any of the protocols assessed. Furthermore, some values were found to be above not only those observed with the smaller doses, but also above untreated controls. It is concluded that a single dose of 200 g/kg of BB10010 offers the most consistent reduction of mitotic cells, and is, therefore, considered optimal for assessment of radioprotection. 相似文献
102.
Three-dimensional esophageal varix model quantification of variceal volume by high-resolution endoluminal US 总被引:2,自引:0,他引:2
Chung CY McCray WH Dhaliwal S Haywood T Black M Liu JB Miller LS 《Gastrointestinal endoscopy》2000,52(1):87-90
BACKGROUND: The purpose of this study was to evaluate the accuracy and reproducibility of three-dimensional volume measurements by high-resolution endoluminal ultrasound in an esophageal varix model. METHODS: An esophageal varix model was made by filling three esophageal dilatation catheters with various volumes of water. A 20 MHz ultrasonography transducer was then pulled along the length of the catheters at a constant rate (1.25 mm/sec) while videotaping the procedure. Cross-sectional surface area measurements of each catheter were taken every second and the cross-sectional surface area was multiplied by the length of each catheter, as determined by high-resolution endoluminal ultrasound, to determine the volume in each catheter. Interobserver variability was calculated, and three-dimensional reconstruction was performed. RESULTS: The measured volumes corresponded closely with the actual volumes with an error ranging from 0% to 15.4%. The correlation between actual and measured volumes was r = 0.988. The interobserver variability ranged from r = 0.951 to r = 0.994. Actual esophageal varices were then imaged in a similar fashion to determine the feasibility of this method in patients with esophageal varices. CONCLUSIONS: High-resolution endoluminal ultrasound is an accurate and reproducible method of measuring volumes in an esophageal varix model and can be used in a clinical setting to determine variceal volume. Volume studies are now underway in human subjects. 相似文献
103.
104.
Anil Rana Jimi Marin Alex Monika Chauhan Gaurav Joshi Raj Kumar 《Medicinal chemistry research》2015,24(3):903-920
Past few decades have witnessed the dawn of new diseases in which cancer is a major problem and the race ensued to eradicate cancer by charting out various effective therapeutic regimens. Circumventing resistance issues and combating the toxicity and selectivity problems are matter-of-concern in cancer treatment. Persistent failure to ensure complete remission and eradication of cancer instigated the researchers to exploit the strategies of combining pharmacophores as targeted therapeutic agents. Momentous improvement in the pharmacokinetic as well as pharmacodynamic profile resulting in the enhancement of bioavailability was seen with the introduction of these pharmacophores. The scope of molecular hybridization can be clearly exemplified through the US-FDA approved estramustine and others such as CUDC-101, CBLC-137, PLX3397, E-3810, and CUDC-907 that are currently in different phases of clinical trials. This review seeks to highlight and discuss anti-proliferative activity of some important hybrid, dual, and multi-targeted pharmacophores reported to date along with their designs, structure activity relationships, scope, and limitations. Further, an emphasis has been made to summarize US-FDA approved as well as drugs currently undergoing clinical trials of anticancer drug development. 相似文献
105.
106.
107.
108.
Roy O. Weller Cheryl A. Hawkes Raj N. Kalaria David J. Werring Roxana O. Carare 《Brain pathology (Zurich, Switzerland)》2015,25(1):63-78
White matter abnormalities on magnetic resonance imaging (MRI) are associated with dementia and include white matter hyperintensities (WMH; also termed leukoaraiosis) and visible perivascular spaces (PVS). We review the potential role of impaired drainage of interstitial fluid in the pathogenesis of WMH and PVS. Whereas the volume of extracellular space in the grey matter is tightly controlled, fluid accumulates and expands the extracellular spaces of the white matter in acute hydrocephalus, vasogenic edema and WMH. Although there are no conventional lymphatic vessels in the brain, there is very effective lymphatic drainage for fluid and solutes along restricted pathways in the basement membranes of cerebral capillaries and arteries in young individuals. Lymphatic drainage of the brain is impaired with age and in association with apolipoprotein E ε4, risk factors for Alzheimer's disease and cerebral amyloid angiopathy (CAA). Deposition of proteins in the lymphatic drainage pathways in the walls of cerebral arteries with age is recognized as protein elimination failure angiopathy (PEFA), as in CAA and cerebral autosomal dominant arteriopathy and leukoencephalopathy (CADASIL). Facilitating perivascular lymphatic drainage from the aging brain may play a significant role in the prevention of CAA, WMH and Alzheimer's disease and may enhance the efficacy of immunotherapy for Alzheimer's disease. 相似文献
109.
A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older Adults
Jessica E. Lockery Jonathan C. Broder Joanne Ryan Ashley C. Stewart Robyn L. Woods Trevor T.-J. Chong Geoffrey C. Cloud Anne Murray Jason D. Rigby Raj Shah Elsdon Storey Stephanie A. Ward Rory Wolfe Christopher M. Reid Taya A. Collyer Michael E. Ernst 《Journal of general internal medicine》2021,36(6):1629
BackgroundAnticholinergic medications may increase risk of dementia and stroke, but prospective studies in healthy older people are lacking.ObjectiveCompare risk of incident dementia and stroke by anticholinergic burden among initially healthy older people.DesignProspective cohort study.SettingPrimary care (Australia and USA).Participants19,114 community-dwelling participants recruited for the ASPREE trial, aged 70+ years (65+ if US minorities) without major cardiovascular disease, dementia diagnosis, or Modified Mini-Mental State Examination score below 78/100.MeasurementsBaseline anticholinergic exposure was calculated using the Anticholinergic Cognitive Burden (ACB) score. Dementia was adjudicated using Diagnostic and Statistical Manual of Mental Disorders volume IV criteria, and stroke using the World Health Organization definition.ResultsAt baseline, 15,000 participants (79%) had an ACB score of zero, 2930 (15%) a score of 1–2, and 1184 (6%) a score of ≥ 3 (indicating higher burden). After a median follow-up of 4.7 years and adjusting for baseline covariates, a baseline ACB score of ≥ 3 was associated with increased risk of ischemic stroke (adjusted HR 1.58, 95% CI 1.06, 2.35), or dementia (adjusted HR 1.36, 95% CI 1.01, 1.82), especially of mixed etiology (adjusted HR 1.53, 95% CI 1.06, 2.21). Results were similar for those exposed to moderate/highly anticholinergic medications.LimitationsResidual confounding and reverse causality are possible. Assessment of dose or duration was not possible.ConclusionsHigh anticholinergic burden in initially healthy older people was associated with increased risk of incident dementia and ischemic stroke. A vascular effect may underlie this association. These findings highlight the importance of minimizing anticholinergic exposure in healthy older people.Supplementary InformationThe online version contains supplementary material available at 10.1007/s11606-020-06550-2.KEY WORDS: anticholinergic burden, dementia, stroke, potentially inappropriate medication 相似文献
110.
Watson RE Stein AD Dwamena FC Kroll J Mitra R McIntosh BA Vasilenko P Holmes-Rovner MM Chen Q Kupersmith J;Michigan State University Inter-Institutional Collaborative Heart Study Group 《Journal of general internal medicine》2001,16(4):227-234
OBJECTIVE: To assess the influence of race and gender influence on the use of invasive procedures in patients with acute myocardial infarction (AMI) in community hospitals. DESIGN: Prospective, observational. SETTING: Five mid-Michigan community hospitals. PATIENTS: All patients (838) identified with AMI between January 1994 and April 1995 in 1 of these hospitals. MEASUREMENTS AND MAIN RESULTS: After adjusting for age, hospital of admission, insurance type, severity of AMI, and comorbidity, using white men as the reference group, the rate of being offered cardiac catheterization (CC) was 0.88 (95% confidence interval [95% CI], 0.60 to 1.29) for white women; 0.79 (95% CI, 0.41 to 1.50) for black men; and 1.14 (95% CI, 0.53 to 2.45)for black women. Among patients who underwent CC, after also adjusting for coronary artery anatomy, the rate of being offered angioplasty, using white men as the reference group, was 1.22 (95% CI, 0.75 to 1.98) for white women; 0.61 (5% CI, 0.29 to 1.28, P =.192) for black men; and 0.40 (95% CI, 0.14 to 1.13) for black women The adjusted rate of being offered bypass surgery was 0.47 (95% CI, 0.24 to 0.89) for white women; 0.36 (95% CI, 0.12 to 1.06) for black men; and 0.37 (95% CI, 0.11 to 1.28)for black women. CONCLUSIONS: Our study shows that white women are less likely than white men to be offered bypass surgery after AMI. Although black men and women with AMI are less likely than white men to be offered percutaneous transluminal coronary angioplasty or coronary artery bypass grafting in both unadjusted and adjusted analyses, these findings did not reach statistical significance. Our study is limited in power due to the small number of blacks in the sample. 相似文献